Sp911
THE OBESITY EPIDEMIC: A CALL TO ACTION FOR GASTROENTEROLOGY TRAINING
Date
May 8, 2023
Explore related products in the following collection:
Society: AGA
This session, designed for the fellows, clinician educator and program director focuses on designing and delivering curricula for GI fellows on the topics of nutrition, including the obesity epidemic. After a review of the current state and vision or the future, three clinician educators and nutrition experts will highlight resources and approaches to address this vital topics that most training programs struggle to cover. Unique to this session will be the collaboration with a dietician to discuss an approach for interprofessional training in GI using, a core component of ACGME program requirements.
This session, designed for the fellows, clinician educator and program director focuses on designing and delivering curricula for GI fellows on the topics of nutrition, including the obesity epidemic. After a review of the current state and vision or the future, three clinician educators and nutrition experts will highlight resources and approaches to address this vital topics that most training programs struggle to cover. Unique to this session will be the collaboration with a dietician to discuss an approach for interprofessional training in GI using, a core component of ACGME program requirements.
Presenter
Tracks
Related Products
ENDOSCOPIC ULTRASOUND LIVER PALPATION AS A SCREENING TOOL FOR ADVANCED FIBROSIS AND CIRRHOSIS
BACKGROUND: Hepatic encephalopathy (HE) is associated with increased mortality, falls, and frequent hospitalizations. Patient reported outcomes (PROs) are useful tools to assess health-related quality of life (HRQOL) measures such as impairment of sleep, cognition, or activity…
ENDOSCOPIC SLEEVE GASTROPLASTY WITH ANTI-OBESITY MEDICATIONS: ANALYSIS OF COMBINATION THERAPY, OPTIMAL TIMING AND AGENTS
Background: Transoral outlet reduction endoscopy (TORe) has been shown to be effective in managing weight regain after Roux-en-Y gastric bypass (RYGB), as has the glucagon-like peptide-1 agonist, liraglutide. However, the effect of adjunctive liraglutide after TORe has yet to be assessed…
PANEL DISCUSSION
This session, designed for the fellows, clinician educator and program director focuses on designing and delivering curricula for GI fellows on the topics of nutrition, including the obesity epidemic…
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
